Robert J Eom
Examiner (ID: 14076, Phone: (571)270-7075 , Office: P/1797 )
Most Active Art Unit | 1797 |
Art Unit(s) | 1797, 1772 |
Total Applications | 735 |
Issued Applications | 359 |
Pending Applications | 80 |
Abandoned Applications | 194 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18860390
[patent_doc_number] => 20230414824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => ANTIMICROBIAL OR WOUND CARE MATERIALS, DEVICES AND USES
[patent_app_type] => utility
[patent_app_number] => 18/215019
[patent_app_country] => US
[patent_app_date] => 2023-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18215019
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/215019 | ANTIMICROBIAL OR WOUND CARE MATERIALS, DEVICES AND USES | Jun 26, 2023 | Pending |
Array
(
[id] => 18707534
[patent_doc_number] => 20230330110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => HARD CAPSULE DOSAGE FORM AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/199117
[patent_app_country] => US
[patent_app_date] => 2023-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18199117
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/199117 | HARD CAPSULE DOSAGE FORM AND USES THEREOF | May 17, 2023 | Pending |
Array
(
[id] => 18672879
[patent_doc_number] => 20230310325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
[patent_app_type] => utility
[patent_app_number] => 18/160445
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160445
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160445 | High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients | Jan 26, 2023 | Pending |
Array
(
[id] => 18359304
[patent_doc_number] => 20230140895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => OPHTHALMIC SUSPENSION COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/086286
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086286
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086286 | OPHTHALMIC SUSPENSION COMPOSITION | Dec 20, 2022 | Pending |
Array
(
[id] => 18281107
[patent_doc_number] => 20230096579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => ANTISEPTIC WOUND DRESSING
[patent_app_type] => utility
[patent_app_number] => 18/062678
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062678
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062678 | ANTISEPTIC WOUND DRESSING | Dec 6, 2022 | Pending |
Array
(
[id] => 18800107
[patent_doc_number] => 11833253
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-05
[patent_title] => Extended release pharmaceutical composition of Clozapine
[patent_app_type] => utility
[patent_app_number] => 17/967244
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4840
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17967244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/967244 | Extended release pharmaceutical composition of Clozapine | Oct 16, 2022 | Issued |
Array
(
[id] => 18323185
[patent_doc_number] => 20230121313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => INTRANASAL ADMINISTRATION OF ESKETAMINE
[patent_app_type] => utility
[patent_app_number] => 17/890039
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 128754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890039 | INTRANASAL ADMINISTRATION OF ESKETAMINE | Aug 16, 2022 | Pending |
Array
(
[id] => 18229114
[patent_doc_number] => 20230068108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => COMPOSITION AND METHOD HAVING ENHANCED LSESr TO MAINTAIN AND PROMOTE HAIR HEALTH AND GROWTH
[patent_app_type] => utility
[patent_app_number] => 17/818013
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/818013 | COMPOSITION AND METHOD HAVING ENHANCED LSESr TO MAINTAIN AND PROMOTE HAIR HEALTH AND GROWTH | Aug 7, 2022 | Pending |
Array
(
[id] => 18043629
[patent_doc_number] => 11517562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/829736
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 28105
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/829736 | Pharmaceutical compositions | May 31, 2022 | Issued |
Array
(
[id] => 18299166
[patent_doc_number] => 20230108852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D
[patent_app_type] => utility
[patent_app_number] => 17/752418
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17752418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/752418 | CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D | May 23, 2022 | Pending |
Array
(
[id] => 18784044
[patent_doc_number] => 20230371520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => Antimicrobial Polymer Composite
[patent_app_type] => utility
[patent_app_number] => 17/750760
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750760
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/750760 | Antimicrobial Polymer Composite | May 22, 2022 | Pending |
Array
(
[id] => 17790317
[patent_doc_number] => 20220249408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Articles with Active Agent Concentrated at the Substrate Contacting Surface and Related Methods
[patent_app_type] => utility
[patent_app_number] => 17/660515
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17660515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/660515 | Articles with Active Agent Concentrated at the Substrate Contacting Surface and Related Methods | Apr 24, 2022 | Pending |
Array
(
[id] => 17958735
[patent_doc_number] => 20220339315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => ORGANOHYDROGEL FIBERS FOR SIMULTANEOUS RELEASE CONTROL OF HYDROPHILIC AND HYDROPHOBIC SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 17/724997
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17724997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/724997 | ORGANOHYDROGEL FIBERS FOR SIMULTANEOUS RELEASE CONTROL OF HYDROPHILIC AND HYDROPHOBIC SUBSTANCES | Apr 19, 2022 | Pending |
Array
(
[id] => 17958606
[patent_doc_number] => 20220339186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/724105
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17724105
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/724105 | Proton-binding polymers for oral administration | Apr 18, 2022 | Issued |
Array
(
[id] => 17748100
[patent_doc_number] => 20220226303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => MULTI-PHASE DELIVERY COMPOSITIONS AND PRODUCTS INCORPORATING SUCH COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/715274
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715274
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715274 | MULTI-PHASE DELIVERY COMPOSITIONS AND PRODUCTS INCORPORATING SUCH COMPOSITIONS | Apr 6, 2022 | Pending |
Array
(
[id] => 17748011
[patent_doc_number] => 20220226214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => METHOD FOR STABILIZING RETINOIC ACID PRECURSORS AND A SKIN BENEFIT COMPOSITION WITH STABILIZED RETINOIC ACID PRECURSORS
[patent_app_type] => utility
[patent_app_number] => 17/713573
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713573 | Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors | Apr 4, 2022 | Issued |
Array
(
[id] => 17748224
[patent_doc_number] => 20220226427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/711932
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711932 | OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE | Mar 31, 2022 | Pending |
Array
(
[id] => 17702778
[patent_doc_number] => 20220202784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHODS AND COMPOSITIONS FOR INCREASING THE EFFECTIVENESS OF ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/697298
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697298
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697298 | METHODS AND COMPOSITIONS FOR INCREASING THE EFFECTIVENESS OF ANTIVIRAL AGENTS | Mar 16, 2022 | Abandoned |
Array
(
[id] => 17944294
[patent_doc_number] => 20220331311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/653838
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653838
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653838 | TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF | Mar 6, 2022 | Abandoned |
Array
(
[id] => 17805675
[patent_doc_number] => 20220257510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => Compositions for Nanoemulsion Delivery Systems
[patent_app_type] => utility
[patent_app_number] => 17/676573
[patent_app_country] => US
[patent_app_date] => 2022-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676573 | Compositions for Nanoemulsion Delivery Systems | Feb 20, 2022 | Pending |